Streetbeat News

Equity Actions

CNS

NFLX

RWOD

Netflix shares dropped 7% following Q1 financial results. Cohen & Steers shares rose 7% as it's set to join the S&P SmallCap 600. Redwoods Acquisition shares surged 217% after shareholders approved its merger with Anew Medical.

Portfolio Pulse from ryanfaloona@benzinga.com

April 19, 2024 | 12:36 pm

BNIX

Bannix Acquisition Corp. has announced an extension of the deadline to complete its initial business combination from April 14, 2024, to May 14, 2024.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 12:23 pm

KBH

KB Home (NYSE:KBH) announced a $1 billion stock repurchase plan and a 25% increase in its quarterly dividend, from $0.20 to $0.25 per share. This move follows a prior authorization with $113.6 million remaining and is part of a strategy to return value to shareholders while maintaining growth. The company plans to repurchase $200-$400 million in shares in 2024, including $50 million already completed in Q1. The dividend increase results in an annualized rate of $1.00 per share, reflecting a 1.6% yield based on the April 17, 2024 closing price. KB Home's strong balance sheet, with $668.1 million in cash and equivalents as of February 29, 2024, supports these initiatives. KBH shares saw a 1.04% increase in premarket trading to $61.04.

Portfolio Pulse from Shivani Kumaresan

April 19, 2024 | 12:21 pm

NSC

Norfolk Southern Corp. has labeled the near-term targets set by Ancora Alternatives LLC as 'highly unrealistic' and is urging its shareholders to vote for the company's nominees instead of those proposed by Ancora. This dispute highlights a significant disagreement between the railroad company and the investment firm regarding the strategic direction and management goals.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 12:06 pm

INSP

Inspire Medical Systems (NYSE:INSP) received mixed analyst ratings with a recent shift towards a more bullish outlook. The latest ratings from 7 analysts show an increase in the average 12-month price target to $267.57, up 8.47% from the previous $246.67. Analyst actions include maintaining and raising price targets, reflecting positive market conditions and company performance. Inspire Medical Systems, specializing in minimally invasive solutions for obstructive sleep apnea, shows strong revenue growth and solid financial performance, despite challenges in profitability and equity capital utilization.

Portfolio Pulse from Benzinga Insights

April 19, 2024 | 12:01 pm

SQ

In the past three months, 23 analysts have provided diverse ratings for Block (NYSE:SQ), with a recent shift towards more bullish sentiments. The average 12-month price target for SQ has been raised to $89.83, up 8.73% from $82.62, reflecting positive adjustments by analysts. Key financial indicators show Block's revenue growth outpacing peers, but challenges in profitability and efficiency metrics like net margin, ROE, and ROA. The company's conservative debt management is noted with a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

April 19, 2024 | 12:01 pm

JWN

Analysts have varied opinions on Nordstrom (JWN), with recent ratings showing a mix of indifference and slight bearishness. The average 12-month price target is $17.9, reflecting a 9.15% increase from the previous target. Analyst actions include maintaining, raising, and lowering ratings and price targets, indicating a nuanced view of Nordstrom's market performance. The company's financial health is highlighted by its market capitalization, revenue growth, net margin, ROE, ROA, and debt management, suggesting a complex but potentially promising investment landscape.

Portfolio Pulse from Benzinga Insights

April 19, 2024 | 12:01 pm

NURO

NeuroMetrix has appointed Joshua S. Horowitz as a new independent director and has terminated its at-the-market equity facility. These strategic moves could signal a shift in the company's governance and financial strategy, potentially impacting investor sentiment and the company's future direction.

Portfolio Pulse from Benzinga Newsdesk

April 19, 2024 | 12:01 pm

RRR

Recent analyst ratings for Red Rock Resorts (NASDAQ:RRR) show a predominantly bullish outlook, with 12 analysts offering insights that led to an average 12-month price target of $61.75, reflecting a 12.09% increase from the previous target. The company's financial overview highlights a below-industry-average market capitalization, notable revenue growth of 8.75% over three months, exceptional net margin and ROE, impressive ROA, but a high debt-to-equity ratio indicating substantial debt.

Portfolio Pulse from Benzinga Insights

April 19, 2024 | 12:00 pm

ACM

AECOM (NYSE:ACM) received mixed analyst ratings with an updated average 12-month price target of $104.6, reflecting a 6.73% increase from the previous target. The analysis included ratings from Keybanc, Truist Securities, Barclays, RBC Capital, and Baird, with adjustments indicating a generally positive outlook. AECOM's financial performance shows robust revenue growth and strong ROE, despite challenges in net margin, ROA, and high debt levels. The company's significant scale and market position are highlighted by its global presence and sales figures.

Portfolio Pulse from Benzinga Insights

April 19, 2024 | 12:00 pm